Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0G6PL
|
||||
| Former ID |
DIB015635
|
||||
| Drug Name |
LG-2293
|
||||
| Synonyms |
LG-121100
|
||||
| Indication | Prostate cancer [ICD9: 185; ICD10:C61] | Terminated | [546195] | ||
| Company |
Ligand Pharmaceuticals Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Androgen receptor | Target Info | Modulator | [546196] | |
| Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
| Coregulation of Androgen receptor activity | |||||
| Regulation of Androgen receptor activity | |||||
| Nongenotropic Androgen signaling | |||||
| Regulation of nuclear beta catenin signaling and target gene transcription | |||||
| FOXA1 transcription factor network | |||||
| Notch-mediated HES/HEY network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.